Frisco Startup Lands First U.S. Authorization for COVID-19 Breathalyzer Test

Written By Jake Hamann

Frisco-based InspectIR received the FDA emergency use authorization on Friday for its breathalyzer test, which tests for organic compounds associated with COVID-19 in a person's breath. According to a study, the tests are more effective than the rapid antigen tests available for free from the U.S. government.

Jake Hamann https://jakehamann.me
Previous

Dallas Business Journal's Women in Technology Class of 2022 – Danyel Surrency Jones
Next

Frisco EDC’s First Director of Innovation Will Focus on Startups, Tech, and Venture Capital